MARKET

JAGX

JAGX

Jaguar Health Inc
NASDAQ
1.040
+0.055
+5.62%
After Hours: 1.050 +0.01 +0.96% 16:08 11/22 EST
OPEN
0.9865
PREV CLOSE
0.9847
HIGH
1.050
LOW
0.9631
VOLUME
275.22K
TURNOVER
--
52 WEEK HIGH
30.86
52 WEEK LOW
0.9000
MARKET CAP
12.27M
P/E (TTM)
-0.0523
1D
5D
1M
3M
1Y
5Y
1D
Jaguar Health seeking partner to develop, commercialize NP300
TipRanks · 7h ago
Weekly Report: what happened at JAGX last week (1111-1115)?
Weekly Report · 4d ago
Jaguar Health Sees Revenue Growth with New Product Launches
TipRanks · 11/14 04:24
Jaguar Health Inc reports results for the quarter ended September 30 - Earnings Summary
Reuters · 11/13 14:17
Jaguar Health reports Q3 EPS ($1.05) vs. ($22.50) last year
TipRanks · 11/13 14:10
Jaguar Health GAAP EPS of -$1.05, revenue of $3.11M
Seeking Alpha · 11/13 13:11
JAGUAR HEALTH INC: QTRLY REV $3.1 MLN
Reuters · 11/13 13:09
Exploring Jaguar Health's Earnings Expectations
Benzinga · 11/12 21:03
More
About JAGX
Jaguar Health, Inc. is a commercial-stage pharmaceuticals company. The Company is focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress. It operates through two segments: human health and animal health. The animal health segment is focused on developing and commercializing prescription and non-prescription products for companion and production animals. The human health segment is focused on developing and commercializing of human products and the ongoing commercialization of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with human immunodeficiency virus (HIV)/ acquired immunodeficiency syndrome (AIDS) on antiretroviral therapy. The Canalevia-CA1 is for the treatment of chemotherapy-induced diarrhea (CID) in dogs. Its subsidiary Napo Pharmaceuticals, Inc. focuses on developing and commercializing human prescription pharmaceuticals.

Webull offers Jaguar Health Inc stock information, including NASDAQ: JAGX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JAGX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JAGX stock methods without spending real money on the virtual paper trading platform.